RLAY
Relay Therapeutics Inc
Price:  
4.43 
USD
Volume:  
4,003,225.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

RLAY Probability of Bankruptcy

The Probability of Bankruptcy of Relay Therapeutics Inc (RLAY) is 31.85% . This number represents the probability that RLAY will face financial distress in the next 24 months given its current fundamentals and market conditions.

Multiple factors are taken into account when calculating RLAY's probability of bankruptcy : Altman Z-score, Beneish M-score, financial position, macro environments, academic research about distress risk and more.

RLAY - ESG ratings

ESG ratings are directly linked to the cost of capital and RLAY's ability to raise funding, both of which can significantly affect the probability of Relay Therapeutics Inc going bankrupt.

ESG Score 64.20
Environment Score 35.97
Social Score 99.00
Governance Score 57.63
Returns
Historical Returns (5 day) 7.06%
Historical Returns (MTD) -%
Historical Returns (YTD) -57.31%
Historical Returns (13 week) -50.58%
Historical Returns (26 week) -35.97%
Historical Returns (52 week) -49.84%
Efficiency
Asset Turnover 0.07
Receiveable Turnover 19.65
Gross Margin
Operating Margin -1,056.29%
Pretax Margin -965.29%
Net Margin -965.29%
Return on Asset (ROA) -71.27
Return on Equity (ROE) -80.00
Return on Investments (ROI) -80.00
Price Metrics
Market Cap (M) 741.49
Enterprise Value (M)
52 Week High 12.14
52 Week Low 4.25
Beta 2.14
Average Volume (10 day) 2.23
Average Volume (3 month) 1.92
Price / Earnings (P/E)
Price / Sales (P/S) 12.92
Earnings
EPS -4.73
Revenue CAGR (5 year)
Risk
Current Ratio 18.42
Quick Ratio 18.02